These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23313887)
1. Baculovirus vector as an avian influenza vaccine: hemagglutinin expression and presentation augment the vaccine immunogenicity. Chen CY; Lin SY; Cheng MC; Tsai CP; Hung CL; Lo KW; Hwang Y; Hu YC J Biotechnol; 2013 Mar; 164(1):143-50. PubMed ID: 23313887 [TBL] [Abstract][Full Text] [Related]
2. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms. Chen CY; Liu HJ; Tsai CP; Chung CY; Shih YS; Chang PC; Chiu YT; Hu YC Vaccine; 2010 Nov; 28(48):7644-51. PubMed ID: 20883735 [TBL] [Abstract][Full Text] [Related]
3. Construction of recombinant baculoviruses expressing hemagglutinin of H5N1 avian influenza and research on the immunogenicity. Ge J; An Q; Gao D; Liu Y; Ping W Sci Rep; 2016 Apr; 6():24290. PubMed ID: 27063566 [TBL] [Abstract][Full Text] [Related]
4. The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines. Garg S; Oran AE; Hon H; Jacob J J Immunol; 2004 Jul; 173(1):550-8. PubMed ID: 15210816 [TBL] [Abstract][Full Text] [Related]
6. Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses. Wang Z; Gao J; Yu Q; Yang Q Future Microbiol; 2012 Aug; 7(8):1003-10. PubMed ID: 22913358 [TBL] [Abstract][Full Text] [Related]
7. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Yang DG; Chung YC; Lai YK; Lai CW; Liu HJ; Hu YC Mol Ther; 2007 May; 15(5):989-96. PubMed ID: 17375072 [TBL] [Abstract][Full Text] [Related]
8. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Tang XC; Lu HR; Ross TM Vaccine; 2010 Oct; 28(42):6821-31. PubMed ID: 20727393 [TBL] [Abstract][Full Text] [Related]
9. Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice. Hu X; Meng W; Dong Z; Pan W; Sun C; Chen L Virus Res; 2011 Jan; 155(1):156-62. PubMed ID: 20883733 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system. Na HN; Kim KH; Song MK; Park HL; Lee EY; Shim SH; Park S; Nam JH Microbiol Immunol; 2013 Sep; 57(9):660-4. PubMed ID: 23822120 [TBL] [Abstract][Full Text] [Related]
11. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus. Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708 [TBL] [Abstract][Full Text] [Related]
12. Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice. Prabakaran M; Madhan S; Prabhu N; Geng GY; New R; Kwang J Antiviral Res; 2010 May; 86(2):180-7. PubMed ID: 20153776 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the immune response to recombinant DNA vaccine and adenoviral vaccine co-expressing the M1 and HA genes of H5N1 influenza virus in mice. Guo J; Yao L; Chen A; Liu X; Fu J; Xu P; Zhang Z Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):876-83. PubMed ID: 22034816 [TBL] [Abstract][Full Text] [Related]
14. Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1). Yang SG; Wo JE; Li MW; Mi FF; Yu CB; Lv GL; Cao HC; Lu HF; Wang BH; Zhu H; Li LJ Vaccine; 2009 Dec; 27(52):7451-8. PubMed ID: 19450640 [TBL] [Abstract][Full Text] [Related]
15. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483 [TBL] [Abstract][Full Text] [Related]
17. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice. Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537 [TBL] [Abstract][Full Text] [Related]
18. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973 [TBL] [Abstract][Full Text] [Related]
19. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice. Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708 [TBL] [Abstract][Full Text] [Related]
20. Baculovirus surface display of the HA protein of H5N2 avian influenza virus and its immunogenicity against a lethal challenge with H5N1 virus in chickens. Tung MC; Lu HY; Chang YK; Huang WR; Liao TL; Wu HY; Chang CD; Fan HC; Nielsen BL; Liu HJ Vet Microbiol; 2020 Apr; 243():108640. PubMed ID: 32273019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]